Detalles de la búsqueda
1.
HIV envelope antibodies and TLR7 agonist partially prevent viral rebound in chronically SHIV-infected monkeys.
PLoS Pathog
; 18(4): e1010467, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35452496
2.
Targeting HIV Reservoir in Infected CD4 T Cells by Dual-Affinity Re-targeting Molecules (DARTs) that Bind HIV Envelope and Recruit Cytotoxic T Cells.
PLoS Pathog
; 11(11): e1005233, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26539983
3.
Bispecific antibodies directed to CD4 domain 2 and HIV envelope exhibit exceptional breadth and picomolar potency against HIV-1.
Proc Natl Acad Sci U S A
; 110(33): 13540-5, 2013 Aug 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-23878231
4.
V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.
J Acquir Immune Defic Syndr
; 71(3): 237-45, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26413851
5.
Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas.
mBio
; 6(2)2015 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25900654
6.
Mitochondrial proliferation, DNA depletion and adipocyte differentiation in subcutaneous adipose tissue of HIV-positive HAART recipients.
Antivir Ther
; 8(4): 323-31, 2003 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-14518702
7.
Rational design and characterization of the novel, broad and potent bispecific HIV-1 neutralizing antibody iMabm36.
J Acquir Immune Defic Syndr
; 66(5): 473-83, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24853313
8.
Anti-CD4 monoclonal antibody ibalizumab exhibits breadth and potency against HIV-1, with natural resistance mediated by the loss of a V5 glycan in envelope.
J Acquir Immune Defic Syndr
; 62(1): 1-9, 2013 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23023102
Resultados
1 -
8
de 8
1
Próxima >
>>